Good news today for generic drugmaker Mylan (Nasdaq: MYL ) . The company's share price popped more than 4%, after releasing a solid earnings report today. The year-over-year earnings per share this quarter were impressive, and revenue increased by 15%.
In the following video, health care analysts Max Macaluso and David Williamson dive into these results and discuss the key take-aways from this report.
Huge gains in the biotech and pharmaceuticals sectors are nothing unusual. The best investing approach is to choose great companies and stick with them for the long term. In our free report, "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.